Compare DexCom, Inc. (DXCM) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Heron Therapeutics Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: DexCom, Inc. is far larger — about 549.7× Heron Therapeutics Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | HRTX | |
|---|---|---|
Market Cap | $33.79B | $61.47M |
Sector | Health | Health |
52-Week High | $89.53 | $1.49 |
52-Week Low | $54.84 | $0.32 |
Enterprise Value | $33.24B | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
